| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |